Quest for the right Drug
אוגמנטין תרחיף 250 מ"ג/5 מ"ל AUGMENTIN SUSPENSION 250 MG/5 ML (AMOXICILLIN AS TRIHYDRATE, CLAVULANIC ACID AS POTASSIUM SALT)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
אבקה להכנת תרחיף : POWDER FOR ORAL SUSPENSION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Posology : מינונים
4.2 Posology and method of administration Posology Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component. The dose of Augmentin that is selected to treat an individual infection should take into account: • The expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4) • The severity and the site of the infection • The age, weight and renal function of the patient as shown below. The use of alternative presentations of Augmentin (e.g. those that provide higher doses of amoxicillin and/or different ratios of amoxicillin to clavulanic acid) should be considered as necessary (see sections 4.4 and 5.1). For children < 40 kg, this formulation of Augmentin provides a maximum daily dose of 2400 mg amoxicillin/600 mg clavulanic acid, when administered as recommended below. If it is considered that a higher daily dose of amoxicillin is required, it is recommended that another preparation of Augmentin is selected in order to avoid administration of unnecessarily high daily doses of clavulanic acid (see sections 4.4 and 5.1). The duration of therapy should be determined by the response of the patient. Some infections (e.g. osteomyelitis) require longer periods of treatment. Treatment should not be extended beyond 14 days without review (see section 4.4 regarding prolonged therapy). Adults and children ≥ 40 kg should be treated with the adult formulations of Augmentin. Children < 40 kg Lower dose: 20 mg/5 mg/kg/day to 40 mg/10 mg/kg/day given in three divided doses. Higher dose: 40 mg/10 mg/kg/day to: 60 mg/15 mg/kg/day given in three divided doses. 40 mg/10 60 mg/15 40 mg/10 60 mg/15 20 mg/5 m mg/kg/ mg/kg/day 20 mg/5 m mg/kg/ mg/kg/day g/kg/ day. day. . Dose in g/kg/ day. day. . Dose in Body Body Dose in ml Dose in ml ml to be Dose in ml Dose in ml ml to be weight weight to be given to be given to be given to be given (kg) (kg) every 8 given every 8 every 8 given every 8 hours. every 8 hours. hours. every 8 hours. hours. hours. 2.0 0.4 0.6 NR 21.0 2.8 5.6 8.4 3.0 0.4 0.8 NR 22.0 3.0 6.0 8.8 4.0 0.6 1.2 NR 23.0 3.2 6.2 9.2 5.0 0.8 1.4 NR 24.0 3.2 6.4 9.6 6.0 0.8 1.6 NR 25.0 3.4 6.8 10 7.0 1.0 2.0 NR 26.0 3.6 7.0 10.4 8.0 1.2 2.2 NR 27.0 3.6 7.2 10.8 9.0 1.2 2.4 NR 28.0 3.8 7.6 11.2 10.0 1.4 2.8 NR 29.0 4.0 7.8 11.6 11.0 1.6 3.0 NR 30.0 4.0 8.0 12 12.0 1.6 3.2 4.8 31.0 4.2 8.4 12.4 13.0 1.8 3.6 5.2 32.0 4.4 8.6 12.8 14.0 2.0 3.8 5.6 33.0 4.4 8.8 13.2 15.0 2.0 4.0 6 34.0 4.6 9.2 13.6 16.0 2.2 4.4 6.4 35.0 4.8 9.4 14 17.0 2.4 4.6 6.8 36.0 4.8 9.6 14.4 18.0 2.4 4.8 7.2 37.0 5.0 10.0 14.8 19.0 2.6 5.2 7.6 38.0 5.2 10.2 15.2 20.0 2.8 5.4 8 39.0 5.2 10.4 15.6 NR – Not recommended. No clinical data are available on doses of Augmentin 4:1 formulations higher than 40 mg/10 mg/kg per day in children under 2 years. For very young children (including preterm new-borns) in the first week of life the interval of administration should not exceed twice daily administration due to immaturity of the renal pathway of elimination. Alternative oral formulations of Augmentin should be considered to deliver practical dose recommendations. Children may be treated with Augmentin tablets or suspensions. Children aged 6 years and below should preferably be treated with Augmentin suspension. The dose (ml) to be given to the patient three times daily can also be calculated using the following formula below: Recommended amoxicillin* dose (mg/kg/day) x weight (kg) Dose (ml) given = Reconstituted amoxicillin* in suspension (mg/ml) x 3 (daily three times daily doses) * Only consideration of the amoxicillin component is required for this calculation. For example, a 6 kg child treated at 20 mg/5 mg/kg/day: 20 (mg/kg/day) x 6 (kg) Dose (ml) given = 50 (mg/ml) x 3 (daily three times daily doses) Dose (ml) given 120 (mg) = three times daily 150 (mg/ml) Dose (ml) given = 0.8 ml three times daily Elderly No dose adjustment is considered necessary. Elderly patients should preferably be treated with adult formulations of Augmentin. Renal impairment Dose adjustments are based on the maximum recommended level of amoxicillin. No adjustment in dose is required in patients with creatinine clearance (CrCl) greater than 30 ml/min. Children < 40 kg CrCl: 10-30 ml/min 15 mg/3.75 mg/kg twice daily (maximum 500 mg/125 mg twice daily). CrCl < 10 ml /min 15 mg/3.75 mg/kg as a single daily dose (maximum 500 mg/125 mg). Haemodialysis 15 mg/3.75 mg/kg per day once daily. Prior to haemodialysis 15 mg/3.75 mg/kg. In order to restore circulating drug levels, 15 mg/3.75 mg per kg should be administered after haemodialysis. Hepatic impairment Dose with caution and monitor hepatic function at regular intervals (see sections 4.3 and 4.4). Method of administration Augmentin is for oral use. Augmentin should be administered with a meal to minimise potential gastrointestinal intolerance. Therapy can be started parenterally according to the SmPC of the IV-formulation and continued with an oral preparation. Shake to loosen powder, add water as directed, invert and shake. Shake the bottle before each dose (see section 6.6). For instructions on reconstitution of the medicinal product before administration, see section 6.6.
שימוש לפי פנקס קופ''ח כללית 1994
lower & upper respiratory tract infections such as acute otitis media, acute sinusitis, pneumonia, exacerbation of chronic bronchitis caused by beta-lactamase producing H. influenzae and M. catarrhalis or other infections resistant to amoxycillin
תאריך הכללה מקורי בסל
01/01/1995
הגבלות
תרופה שאושרה לשימוש כללי בקופ'ח
מידע נוסף
עלון מידע לצרכן
25.03.18 - עלון לצרכן 12.04.18 - עלון לצרכן 14.07.21 - עלון לצרכן אנגלית 14.07.21 - עלון לצרכן עברית 14.07.21 - עלון לצרכן ערבית 11.06.23 - עלון לצרכן אנגלית 07.06.23 - עלון לצרכן עברית 11.06.23 - עלון לצרכן ערבית 22.08.23 - עלון לצרכן עברית 04.12.23 - עלון לצרכן אנגלית 03.12.23 - עלון לצרכן עברית 04.12.23 - עלון לצרכן ערבית 16.07.24 - עלון לצרכן עברית 29.11.16 - החמרה לעלון 07.04.21 - החמרה לעלון 25.04.21 - החמרה לעלון 31.05.21 - החמרה לעלון 22.08.23 - החמרה לעלון 09.04.24 - החמרה לעלון 16.07.24 - החמרה לעלוןלתרופה במאגר משרד הבריאות
אוגמנטין תרחיף 250 מ"ג/5 מ"ל